Select Country: United States

Systagenix

Let’s Heal™ is the result of 75 years experience in developing our products to help you test, protect, promote and comfort the wound towards healing.

Find out more

PROMOGRAN PRISMAPROMOGRAN PRISMA®


PROMOGRAN PRISMA® matrix is a sterile freeze-dried wound dressing matrix comprised of 55% Collagen and 44% Oxidized Regenerated Cellulose (ORC) and 1% silver -ORC.

 

PROMOGRAN PRISMA helps protect against infection whilst promoting cell growth.1-3


With PROMOGRAN PRISMA® stalled wounds close:

  • Faster5-7
  • Cost effectively8-9
  • While providing protection from infection1


Click this link to view PROMOGRAN PRISMA® product codes

 

© Systagenix Wound Management 2011. Brands marked with ® or ™ are trademarks of Systagenix. All other products referenced herein are acknowledged to be trademarks of their respective owners.

Click here for references

PROMOGRAN PRISMA® references


1. Cullen B et al. ORC/Collagen Matrix Containing Silver Controls Bacterial Bioburden while Retaining Dermal Cell viability. Poster presented at EWMA Prague, May 2006

2. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005

3. Nisi G et al. Use of protease-modulating matrix in the treatment of pressure sores. Chir Ital 2005;57:465-8

4. Lazaro-Martinez et al. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers. F.R. Circ. Esp.2007, 82(1), 27-31

5. Veves A et al. A randomized , controlled trial of PROMOGRAN® (a collagen/oxidised regenerated cellulose dressing) vs standard treatments in the management of diabetic foot ulcers. Arch Surg 2002;137:822-827

6. Cullen, B., Domnelly, T., Rennison, T. Can excessive levels of silver be detrimental to healing? SAWC, San Diego, 2008

7. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005

8. Cullen, B., Nisbet, L., Gibson, M., Lanzara, S., Zamboni, P. A clinical study examining the effect of ORC/Collagen/Silver-ORC on healing and wound biochemistry. SAWC, Dallas, 2009

11. (relates to graph) Cullen, B., Kemp, L., Essler, L. Rebalancing wound biochemistry improves healing: a clinical study examining effect of PROMOGRAN. Wound Repair Regen. 2004 12(2) A4.